Grand Pharmaceutical Group Limited 0512.HK Stock
Grand Pharmaceutical Group Limited Price Chart
Grand Pharmaceutical Group Limited 0512.HK Financial and Trading Overview
| Grand Pharmaceutical Group Limited stock price | 4.03 HKD |
| Previous Close | 4.49 HKD |
| Open | 4.5 HKD |
| Bid | 4.55 HKD x 0 |
| Ask | 4.58 HKD x 0 |
| Day's Range | 4.43 - 4.59 HKD |
| 52 Week Range | 3.28 - 5.4 HKD |
| Volume | 4.13M HKD |
| Avg. Volume | 3.2M HKD |
| Market Cap | 16.15B HKD |
| Beta (5Y Monthly) | 0.939463 |
| PE Ratio (TTM) | 7.844828 |
| EPS (TTM) | 0.54 HKD |
| Forward Dividend & Yield | 0.14 (3.16%) |
| Ex-Dividend Date | June 9, 2023 |
| 1y Target Est | N/A |
0512.HK Valuation Measures
| Enterprise Value | 17.06B HKD |
| Trailing P/E | 7.844828 |
| Forward P/E | 5.2906976 |
| PEG Ratio (5 yr expected) | 0.27 |
| Price/Sales (ttm) | 1.6889838 |
| Price/Book (mrq) | 1.1324042 |
| Enterprise Value/Revenue | 1.784 |
| Enterprise Value/EBITDA | 5.129 |
Trading Information
Grand Pharmaceutical Group Limited Stock Price History
| Beta (5Y Monthly) | 0.939463 |
| 52-Week Change | 2.51% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.4 HKD |
| 52 Week Low | 3.28 HKD |
| 50-Day Moving Average | 4.9 HKD |
| 200-Day Moving Average | 4.39 HKD |
0512.HK Share Statistics
| Avg. Volume (3 month) | 3.2M HKD |
| Avg. Daily Volume (10-Days) | 1.8M HKD |
| Shares Outstanding | 3.55B |
| Float | 1.16B |
| Short Ratio | N/A |
| % Held by Insiders | 61.53% |
| % Held by Institutions | 14.24% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.14 |
| Trailing Annual Dividend Yield | 3.11% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.1874 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 21.74% |
| Operating Margin (ttm) | 31.01% |
| Gross Margin | 62.23% |
| EBITDA Margin | 34.79% |
Management Effectiveness
| Return on Assets (ttm) | 8.53% |
| Return on Equity (ttm) | 15.17% |
Income Statement
| Revenue (ttm) | 9.56B HKD |
| Revenue Per Share (ttm) | 2.7 HKD |
| Quarterly Revenue Growth (yoy) | 7.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | 3.33B HKD |
| Net Income Avi to Common (ttm) | 2.08B HKD |
| Diluted EPS (ttm) | 0.58 |
| Quarterly Earnings Growth (yoy) | 14.09% |
Balance Sheet
| Total Cash (mrq) | 3.31B HKD |
| Total Cash Per Share (mrq) | 0.94 HKD |
| Total Debt (mrq) | 4.5B HKD |
| Total Debt/Equity (mrq) | 31.67 HKD |
| Current Ratio (mrq) | 1.067 |
| Book Value Per Share (mrq) | 4.018 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.84B HKD |
| Levered Free Cash Flow (ttm) | 547.59M HKD |
Profile of Grand Pharmaceutical Group Limited
| Country | Hong Kong |
| State | N/A |
| City | Central |
| Address | The Center |
| ZIP | N/A |
| Phone | N/A |
| Website | https://www.grandpharm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 10172 |
Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It also manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additives; disposal surgical products; and Chinese medicine and health food products, as well as engages in the treatment of sewage. Grand Pharmaceutical Group Limited has a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University in the field of ophthalmic drug research and development. It operates in the People's Republic of China, the rest of Asia, the United States, Europe, and internationally. The company was formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited. Grand Pharmaceutical Group Limited was incorporated in 1995 and is based in Central, Hong Kong.
Q&A For Grand Pharmaceutical Group Limited Stock
What is a current 0512.HK stock price?
Grand Pharmaceutical Group Limited 0512.HK stock price today per share is 4.03 HKD.
How to purchase Grand Pharmaceutical Group Limited stock?
You can buy 0512.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Grand Pharmaceutical Group Limited?
The stock symbol or ticker of Grand Pharmaceutical Group Limited is 0512.HK.
Which industry does the Grand Pharmaceutical Group Limited company belong to?
The Grand Pharmaceutical Group Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Grand Pharmaceutical Group Limited have in circulation?
The max supply of Grand Pharmaceutical Group Limited shares is 3.5B.
What is Grand Pharmaceutical Group Limited Price to Earnings Ratio (PE Ratio)?
Grand Pharmaceutical Group Limited PE Ratio is 7.46296300 now.
What was Grand Pharmaceutical Group Limited earnings per share over the trailing 12 months (TTM)?
Grand Pharmaceutical Group Limited EPS is 0.54 HKD over the trailing 12 months.
Which sector does the Grand Pharmaceutical Group Limited company belong to?
The Grand Pharmaceutical Group Limited sector is Healthcare.